转录组分析揭示与急性髓系白血病进展相关的促炎特征
研究对47例成人和23例儿童AML患者的纵向诊断、复发和/或原发耐药样本进行转录组RNA测序。基因表达分析发现GLI2和IL1R1过表达及ST18下调与短无事件生存相关,CR1下调和DPEP1上调与成人和儿童复发相关。机器学习与网络分析识别CD6过表达和INSR下调为成人AML高度共预测的复发相关基因,提示促炎环境在白血病进展中的重要性。
要点
- GLI2和IL1R1过表达及ST18下调与短无事件生存相关。
- CR1下调和DPEP1上调与成人和儿童AML复发相关。
- CD6过表达和INSR下调为成人AML复发高度共预测基因。
核心结论
- 研究提示促肿瘤炎症环境在AML进展中具有重要作用。
- 所识别的差异表达基因为个性化药物靶点提供基础,有望提高AML治愈率。
研究设计与样本
- 对47例成人和23例儿童AML患者的纵向诊断、复发和/或原发耐药样本进行转录组全RNA测序,患者具有已知突变背景。
主要发现
- GLI2和IL1R1过表达及ST18下调与短无事件生存相关。
- CR1下调和DPEP1上调与成人和儿童AML复发相关。
- 机器学习与网络分析识别CD6过表达和INSR下调为成人AML高度共预测的复发相关基因。
关键数值与推荐
- GLI2和IL1R1过表达及ST18下调与短无事件生存相关。
- CR1下调和DPEP1上调与成人和儿童AML复发相关。
- CD6过表达和INSR下调为成人AML复发高度共预测基因。
临床怎么用
- 上述基因表达特征可能有助于识别短无事件生存和复发风险较高的AML患者。
- 所识别的差异表达基因可为个性化药物靶点开发提供线索。
局限性
- 纵向AML样本的详细分子特征分析仍较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Numerous studies have been performed over the last decade to exploit the complexity of genomic and transcriptomic lesions driving the initiation of acute myeloid leukemia (AML). These studies have helped improve risk classification and treatment options. Detailed molecular characterization of longitudinal AML samples is sparse, however; meanwhile, relapse and therapy resistance represent the main challenges in AML care. To this end, we performed transcriptome-wide RNA sequencing of longitudinal diagnosis, relapse, and/or primary resistant samples from 47 adult and 23 pediatric AML patients with known mutational background. Gene expression analysis revealed the association of short event-free survival with overexpression of GLI2 and IL1R1, as well as downregulation of ST18. Moreover, CR1 downregulation and DPEP1 upregulation were associated with AML relapse both in adults and children. Finally, machine learning-based and network-based analysis identified overexpressed CD6 and downregulated INSR as highly copredictive genes depicting important relapse-associated characteristics among adult patients with AML. Our findings highlight the importance of a tumor-promoting inflammatory environment in leukemia progression, as indicated by several of the herein identified differentially expressed genes. Together, this knowledge provides the foundation for novel personalized drug targets and has the potential to maximize the benefit of current treatments to improve cure rates in AML.
引用
- Stratmann S, Yones SA, Garbulowski M, et al. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. Blood Adv. 2022. PMID: 34619772. doi:10.1182/bloodadvances.2021004962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。